Lower Respiratory Tract Infection Support Protocol

Infectious/RespiratoryModerate Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

Vitamin CB

1000-2000mg daily during infection

Supports immune function; may reduce severity and duration of respiratory infections

↓Upper Respiratory Tract Infection Symptoms

15 studies1,200 participants

Supporting Studies (1)

PMID: 23440782 - Vitamin C for preventing and treating respiratory infections: Cochrane review (2013)

Vitamin DB

2000-4000 IU daily

Supports immune function; deficiency increases infection risk

Lower Respiratory Tract Infection Risk↑Upper Respiratory Tract Infection Risk↓Upper Respiratory Tract Infection Symptoms

12 studies800 participants

Supporting Studies (1)

PMID: 28202713 - Vitamin D supplementation to prevent acute respiratory tract infections: meta-analysis (2017)

Supporting Stack

Additional supplements for enhanced results

ZincB

15-30mg daily

Supports immune response to infections

8 studies500 participants

Supporting Studies (1)

PMID: 22566526 - Zinc for respiratory infections: systematic review (2012)

ProbioticsB

10-20 billion CFU daily

May reduce duration of respiratory infections; supports immune function

10 studies600 participants

Supporting Studies (1)

PMID: 25927096 - Probiotics for respiratory tract infections: Cochrane review (2015)

N-Acetyl CysteineB

600-1200mg daily

Mucolytic; helps thin mucus and supports lung health

8 studies400 participants

Supporting Studies (1)

PMID: 10793665 - NAC for respiratory infections: review (2000)

How This Protocol Works

Simple Explanation

Lower respiratory tract infections (LRTIs) affect the airways below the voice box - the bronchi and lungs. They include bronchitis, bronchiolitis, and pneumonia.

TYPES:

•Acute bronchitis (most common in adults)

•Bronchiolitis (common in infants - usually RSV)

•Pneumonia (lung infection)

•Influenza with lower respiratory involvement

SYMPTOMS:

•Cough (may produce mucus)

•Shortness of breath

•Wheezing

•Chest discomfort or pain

•Fever

•Fatigue

•Rapid breathing

CAUSES:

•Viral (most common - influenza, RSV, adenovirus)

•Bacterial (Streptococcus pneumoniae, H. influenzae, Mycoplasma)

CRITICAL: See a doctor for:

•High fever (>103°F/39.4°C)

•Difficulty breathing

•Blue lips or fingernails

•Coughing up blood

•Symptoms worsening after initial improvement

•Elderly or immunocompromised patients

MEDICAL TREATMENT:

•Antibiotics (if bacterial)

•Antivirals (for influenza)

•Bronchodilators

•Oxygen if needed

•Hospitalization for severe cases

* Vitamin C and D support immune function.

* NAC helps with mucus clearance.

* Bacterial pneumonia requires antibiotics.

Expected timeline: Acute bronchitis: 1-3 weeks. Pneumonia: 1-4 weeks depending on severity. Supplements support recovery.

Clinical Perspective

LRTI: Includes acute bronchitis, bronchiolitis, pneumonia. Etiology: viral most common (influenza, RSV, rhinovirus); bacterial (S. pneumoniae, H. influenzae, M. pneumoniae, Legionella). Risk factors: age extremes, smoking, COPD, immunocompromise.

Treatment: Acute bronchitis usually viral - supportive care, avoid unnecessary antibiotics. Pneumonia: CURB-65 for severity; antibiotics per guidelines (CAP vs HAP). Influenza: oseltamivir within 48h if indicated. Supplements support immune function and mucus clearance but don't replace medical care for moderate-severe LRTI.

* Vitamin C (B-grade): Immune support. Cochrane: (PMID: 23440782). 1000-2000mg daily.

* Vitamin D (B-grade): Infection prevention. Meta-analysis: (PMID: 28202713). 2000-4000 IU daily.

* Zinc (B-grade): Immune function. Systematic review: (PMID: 22566526). 15-30mg daily.

* Probiotics (B-grade): Duration reduction. Cochrane: (PMID: 25927096). 10-20B CFU daily.

* NAC (B-grade): Mucolytic. Review: (PMID: 10793665). 600-1200mg daily.

Protocol notes: Acute bronchitis: 90% viral; antibiotics rarely indicated; cough may persist 3 weeks. Pneumonia: CXR for diagnosis; sputum culture if possible; empiric antibiotics per severity/setting. CURB-65: Confusion, Urea, RR, BP, Age ≥65 - hospitalize if ≥2. Influenza: test and treat high-risk patients. RSV bronchiolitis: supportive care in infants; palivizumab for high-risk. Prevention: pneumococcal vaccine, influenza vaccine, smoking cessation.

View All Protocols